Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs
Published on: Sunday 16 January 2022
Clinical research is expected to begin shortly with the aim for commercialization in 2022 in Antigua and Barbuda. Once approved for sale, the Company will seek commercial partnerships with ...
